Pawel L.
- Country
- Germany
- Department
- -
Research Overview
- Evaluation of Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients with Mild to Moderate Parkinson's Disease and Multiple System Atrophy
- Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018
- Efficacy, Safety, and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Treating Spasticity in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 2 of 116 partner sites.
Specializations
Pediatric Oncology
This investigator specializes in treating pediatric blood disorders, with particular expertise in myeloid leukemia occurring in children with Down syndrome.
- Hematologic Malignancies
- Down Syndrome-Associated Leukemia
- Pediatric Cancer Treatment
The investigator's work involves evaluating innovative therapeutic approaches for children with genetic conditions who develop blood cancers.
Genetic Disease Complications
The investigator focuses on understanding and treating hematological complications specifically associated with chromosomal disorders in pediatric patients.
- Down Syndrome-Related Conditions
- Genetic Disease Management
- Pediatric Blood Disorders
Their research encompasses the unique challenges of treating blood cancers in children with genetic syndromes.
Treatment Innovation
The investigator is involved in advancing therapeutic strategies for complex pediatric conditions, particularly in specialized leukemia treatment protocols.
- Novel Treatment Approaches
- Targeted Therapies
- Clinical Outcomes Research
Their work contributes to developing specialized treatment protocols for unique patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.